Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / February / What Cats Can Tell Us About Cancer
Oncology Liquid biopsy Omics Precision medicine Screening and monitoring Research and Innovations Molecular Pathology

What Cats Can Tell Us About Cancer

Large-scale feline sequencing study highlights diagnostic and therapeutic targets shared with human cancers

02/25/2026 News 1 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll
  • Top Institutions

Share

Clinical Scorecard: What Cats Can Tell Us About Cancer

At a Glance

CategoryDetail
ConditionFeline Cancer
Key MechanismsDriver mutations and genetic alterations mirroring human tumors.
Target PopulationDomestic cats with cancer.
Care SettingVeterinary oncology and comparative oncology research.

Key Highlights

  • Genetic profiling of 493 cats revealed 31 likely driver genes linked to cancer.
  • TP53 mutations were the most frequently observed across tumor types.
  • Feline mammary carcinoma shows strong genetic overlap with human breast cancer.
  • FBXW7 and PIK3CA mutations are common in feline mammary tumors, similar to human cases.
  • Study establishes a genomic reference dataset for feline cancers.

Guideline-Based Recommendations

Diagnosis

  • Utilize targeted sequencing of cancer-associated genes for accurate diagnosis.

Management

  • Consider genotype-guided therapy based on specific mutations in tumors.

Monitoring & Follow-up

  • Regular genomic profiling to track mutations and treatment response.

Risks

  • Environmental factors shared between pets and owners may influence cancer risk.

Patient & Prescribing Data

Cats diagnosed with various types of cancer.

Certain chemotherapies may be more effective in tumors with specific genetic alterations.

Clinical Best Practices

  • Adopt a One Medicine approach to leverage findings in feline cancer for human oncology.
  • Incorporate environmental exposure assessments in cancer risk evaluations.

References

  • Science Journal

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

A Light in the Darkness
Liquid biopsy
A Light in the Darkness

March 4, 2022

2 min read

Spectroscopic liquid biopsy testing – a new route to brain cancer diagnostics

Biomarkers: The Bigger Picture
Liquid biopsy
Biomarkers: The Bigger Picture

April 27, 2022

1 min read

To unlock patient care, pathologists must focus on molecular pathology and ensure efficiency and effectiveness to improve testing. With this testing, patients can benefit from the best treatment to combat their disease.

Benchmarking… Liquid Biopsy
Liquid biopsy
Benchmarking… Liquid Biopsy

May 13, 2022

1 min read

A look at the last five years of publishing on liquid biopsy

Does Your Blood Know You Have Cancer?
Liquid biopsy
Does Your Blood Know You Have Cancer?

July 25, 2022

2 min read

Detection and monitoring are crucial for melanoma outcomes – could a blood test revolutionize both?

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.